Becton, Dickinson and Company (LON:0R19)
London · Delayed Price · Currency is GBP · Price in USD 194.17
-0.16 (-0.08%)
At close: Nov 28, 2025
LON:0R19 Revenue
In the fiscal year ending September 30, 2025, Becton, Dickinson and Company had annual revenue of $21.84B USD with 8.24% growth. Becton, Dickinson and Company had revenue of $5.89B in the quarter ending September 30, 2025, with 8.33% growth.
Revenue
$21.84B
Revenue Growth
+8.24%
P/S Ratio
2.57
Revenue / Employee
$303.33K
Employees
72,000
Market Cap
41.83B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 21.84B | 1.66B | 8.24% |
| Sep 30, 2024 | 20.18B | 806.00M | 4.16% |
| Sep 30, 2023 | 19.37B | 502.00M | 2.66% |
| Sep 30, 2022 | 18.87B | -261.00M | -1.36% |
| Sep 30, 2021 | 19.13B | 3.06B | 19.02% |
| Sep 30, 2020 | 16.07B | -1.22B | -7.03% |
| Sep 30, 2019 | 17.29B | 1.31B | 8.18% |
| Sep 30, 2018 | 15.98B | 3.89B | 32.17% |
| Sep 30, 2017 | 12.09B | -390.00M | -3.12% |
| Sep 30, 2016 | 12.48B | 2.20B | 21.41% |
| Sep 30, 2015 | 10.28B | 1.84B | 21.74% |
| Sep 30, 2014 | 8.45B | 392.00M | 4.87% |
| Sep 30, 2013 | 8.05B | 346.00M | 4.49% |
| Sep 30, 2012 | 7.71B | 124.00M | 1.64% |
| Sep 30, 2011 | 7.58B | 459.62M | 6.45% |
| Sep 30, 2010 | 7.12B | 137.66M | 1.97% |
| Sep 30, 2009 | 6.99B | 89.10M | 1.29% |
| Sep 30, 2008 | 6.90B | 614.78M | 9.79% |
| Sep 30, 2007 | 6.28B | 544.82M | 9.49% |
| Sep 30, 2006 | 5.74B | 397.18M | 7.44% |
| Sep 30, 2005 | 5.34B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| ConvaTec Group | 1.72B |
| Spire Healthcare Group | 1.55B |
| Genus | 672.80M |
Becton, Dickinson and Company News
- 5 days ago - BD Surgiphor™ Surgical Wound Irrigation System Expands to Europe to Help Hospitals Improve Patient Safety - PRNewsWire
- 10 days ago - How Do Investors Really Feel About Becton Dickinson & Co? - Benzinga
- 11 days ago - Becton, Dickinson (BDX) Gains Favor with 1578 Partners Amid Portfolio Shifts - GuruFocus
- 11 days ago - Becton, Dickinson: Our New, Long, Special Situation Investment - Seeking Alpha
- 11 days ago - Becton, Dickinson and Company (BDX) Expands Board with Two New Appointments - GuruFocus
- 12 days ago - BD Appoints Robert Huffines and Jacqueline Wright to Board of Directors - PRNewsWire
- 12 days ago - Becton, Dickinson And Company's BD Onclarity HPV Assay Secures Acceptance To WHO Prequalified List - Nasdaq
- 12 days ago - Becton Dickinson (BDX) Secures Approval for HPV Assay by WHO - GuruFocus